To the central content area
:::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

4107 BIOTEQUE
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
WILLIAM LEE Jin-Long Lin Alex Huang (02)25710269 5F-6,No.23 Sec.1.Chang-An E. Rd .,Taipei 104, Taiwan , R.O.C.    2002/03/04
Industry Main Business
Biotechnology and Medical Care As a life commitment to human being, BIOTEQUE CORPORATION provides Bloodline Set, A.V. Fistula Needle and IV Bags to Hemodialysis patients and other H.D. medical accessories such as Drainage Bag, IV Infusion Set, Burette, Surgical Tube. BIOTEQUE also produces high tech. TPU (Thermo Poly Urethane) implanted catheters such as Pigtail Drainage Catheter and Double J Catheter. All products are distributed in global marketing with success .
 
Market Information ( 2023/02/06 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
449.14 111.50  109.50  110.50  -0.50  525 465 0
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2023/02/06)
TPEx measures
adopted
(2023/02/06)
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.